أعرض في EDS

Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)

التفاصيل البيبلوغرافية
العنوان: Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)
المؤلفون: Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Farrukh T. Awan, Umar Farooq, Siddhartha Ganguly, Peiman Hematti, Michael D. Jain, Partow Kebriaei, Frederick L. Locke, Elena Mead, Taiga Nishihori, Amanda L. Olson, Martina Pennisi, Miguel-Angel Perales, Praveen Ramakrishnan Geethakumari, Roni Shouval, Elizabeth J. Shpall, Margarida Magalhaes Magalhaes-Silverman, Christopher Strouse, Cameron J. Turtle, Anusha Vallurupalli, Kitsada Wudhikam, Marcelo C. Pasquini, Sairah Ahmed, Mohamed Sorror
المصدر: Blood. 140:4636-4638
بيانات النشر: American Society of Hematology, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry
تدمد: 1528-0020
0006-4971
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::01113424fa76ba82171a46cc706dc6eb
https://doi.org/10.1182/blood-2022-169452
رقم الأكسشن: edsair.doi...........01113424fa76ba82171a46cc706dc6eb
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15280020
00064971